GlassScriptPhysician profile
Susan Lee
NPI 1972967065
$2,298.30
in general payments reported to CMS, 2019-2025
18 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2021: $247 · 2022: $864 · 2023: $358 · 2024: $236 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $467.47 | 2021-2024 | Arexvy |
| Novo Nordisk INC | $387.34 | 2022-2025 | Wegovy |
| Abbvie INC. | $247.81 | 2019-2023 | |
| Lilly USA, LLC | $245.80 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $131.79 | 2024-2025 | Farxiga, Airsupra |
| Biohaven Pharmaceuticals, INC. | $124.99 | 2021 | |
| Gilead Sciences, INC. | $120.40 | 2023 | Vemlidy |
| Genzyme Corporation | $119.61 | 2022 | |
| Shionogi INC | $118.62 | 2022 | |
| Csl Behring | $113.08 | 2023 | Kcentra |
| Impel Pharmaceuticals INC. | $98.90 | 2022 | |
| Amarin Pharma, INC. | $23.16 | 2019 | |
| Merck Sharp & Dohme LLC | $22.68 | 2019 | |
| Medtronic, INC. | $21.81 | 2022 | |
| Qol Medical, LLC | $19.48 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $13.85 | 2019 | |
| Amgen INC. | $12.43 | 2019 | |
| Endogastric Solutions, INC | $9.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.